Skip to content
BuildClinical Massachusetts Studies

BuildClinical Massachusetts Studies Facebook ad: “Memory Difficulties Research Study”

BuildClinical Massachusetts Studies Facebook ad: Memory Difficulties Research Study

Ran for 116 days, from June 9 to October 3, 2026, the last day Crush saw it.

Run by BuildClinical Massachusetts Studies on Facebook. Crush is not the advertiser and does not verify its claims. See this ad in Meta's Ad Library(opens in a new tab)

Want an ad like this for your product?

Crush makes new ad images for your product from this ad: your logo, your product photo, your offer.

Trials from $19.95 USD, then $79.95 USD a month. Cancel anytime.

About this ad

Meta Ad Library ID
3726023314203959
Platforms
Facebook, Instagram, Audience Network, Messenger and Threads
Relaunches
0

How we count

Ad text

Interested in being part of a memory difficulties study and supporting clinical research? Qualified participants: ✔️ Ages 55+ ✔️ Experiencing mild to moderate cognitive impairment ✔️ Able to travel to Boston for study visits

studies.buildclinical.com

Memory Difficulties Research Study

Apply Now Non-Invasive Brain Stimulation to Improve Memory & Movement: HomeStim Research Study Harvard faculty and researchers at Hebrew SeniorLife are evaluating the effects of therapeutic at-home non-invasive brain stimulation for improving memory and mobility in older adults diagnosed with cognit...

See details: studies.buildclinical.com(opens in a new tab)

More from BuildClinical Massachusetts Studies

See all BuildClinical Massachusetts Studies ads
  • BuildClinical Massachusetts Studies Facebook ad from May 28, 2026

    Ran 29 days

    1 relaunch

  • BuildClinical Massachusetts Studies Facebook ad: Interested in this Healthy Volunteer study?

    Ran 23 days

  • BuildClinical Massachusetts Studies Facebook ad: Interested in this Healthy Volunteer study?

    Ran 50 days

  • BuildClinical Massachusetts Studies Facebook ad: Infant Sleep Study around Amherst, MA

    Running 77 days

More ads from the top 1,000

See the top 1,000 ads